It is imperative, however, to consider that CTLs additionally require engagement through antigenic presentation in the context of MHC Class I, necessitating attention to a tumor’s CTL Target Score as well as the PD-L1 score prior to the selection of checkpoint blockade immunotherapeutic approaches. Here, CD274 is linked to neoplasm.